-

AHF Advocates to Keep Hammering Gilead CEO over Drug Profiteering

Protest Friday, June 16th will target drug company CEO at company’s Foster City HQ

SAN FRANCISCO--(BUSINESS WIRE)--On Friday, June 16th, advocates and mobilizers affiliated with AIDS Healthcare Foundation (AHF) will host a protest targeting HIV and Hepatitis C drug giant Gilead Sciences over the Bay Area company’s drug pricing and policies. The protest will take place in front of Gilead’s headquarters in Foster City, CA. The action is part of a yearlong aggressive advocacy campaign by AHF hammering Gilead and Daniel O’Day, its multimillionaire CEO, over his and the company’s drug profiteering.

WHAT:

 

Protest at Gilead Sciences HQ

 

 

 

WHEN:

 

Friday, June 16 - 12:00 p.m.

 

 

 

WHERE:

 

Gilead Sciences, Inc. Headquarters

 

 

333 Lakeside Dr., Foster City, CA 94404

 

 

 

WHO:

 

20 health advocates & mobilizers

AHF Onsite Foster City Media Contact: Jesse Brooks, +1.510.575.8245 cell jesse.brooks@ahf.org

According to CEO World Magazine, Daniel O’Day, Chairman and CEO of Gilead Sciences, was the 4th highest paid CEO in the healthcare industry in 2022 with total compensation of $21,621,253.

Advocates are protesting Gilead’s tone-deaf greed, particularly illegal restrictions the company placed early last year on access to 340B drug pricing for its branded hepatitis C treatments for certain pharmacies. Gilead now is one of more than 15 major drug companies that illegally have placed such restrictions on drugs.

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.7 million individuals in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth, follow us @aidshealthcare or subscribe to our AHF podcast “AHFter Hours.”

Contacts

Ged Kenslea, AHF Senior Communications Director
323.791.5526
ged.kenslea@ahf.org

AIDS Healthcare Foundation


Release Summary
Advocates to Keep Hammering Gilead CEO over Drug Profiteering
Release Versions

Contacts

Ged Kenslea, AHF Senior Communications Director
323.791.5526
ged.kenslea@ahf.org

More News From AIDS Healthcare Foundation

Sexual Health Is Health: Testing, Treatment and Prevention for All, says AHF

LOS ANGELES--(BUSINESS WIRE)--As sexually transmitted infections continue to rise worldwide, AIDS Healthcare Foundation (AHF) marks World Sexual Health Day by calling on governments and health systems to expand access to prevention, testing, and treatment services for HIV and other STIs. Despite proven tools to prevent, diagnose, and treat HIV and other STIs, gaps in access continue to put millions of people at risk globally. With an estimated 1.2 million new HIV infections each year globally,...

AHF Webinar Panel Discussion—Freedom from Debt: A Global Dialogue on Fiscal Space, Health, and Development

MIAMI--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), in collaboration with the University of Miami Public Health Policy Lab, will co-host a webinar, “Freedom from Debt: A Global Dialogue on Fiscal Space, Health, and Development,” on Thursday, September 3, 2026, at 10:00 AM EDT, virtually via Zoom. Register here. Sovereign debt has emerged as a defining challenge at the intersection of global finance, sustainable development, and public health. Across many low- and middle-income countries,...

Kelly Rowland Headlines 35th Annual AIDS Walk Music Festival

ATLANTA--(BUSINESS WIRE)--Globally acclaimed, multi-award-winning singer, songwriter and actor, Kelly Rowland is using her star power to shine a spotlight on the ongoing fight against HIV/AIDS. Kelly will be the featured headliner at the 35th Annual AIDS Walk Atlanta Music Festival and 5k Run presented by AHF Pharmacy and Wells Fargo, scheduled for Saturday, September 26, 2026, in the meadow of Atlanta’s Piedmont Park.AIDS Healthcare Foundation (AHF), the world’s largest nonprofit HIV/AIDS healt...
Back to Newsroom